A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia

A Multicenter, Double-blind, Active-controlled, Randomized, Parallel, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia

This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia

Main Inclusion Criteria:

• Men or women aged 19 to 75 years, inclusive
• Subjects diagnosed with functional dyspepsia according to the Rome IV criteria
• Subjects with at least three symptoms rated as moderate or severe on the Gastrointestinal Symptom Score(GIS)
• Subjects who voluntarily signed a consent form

Main Exclusion Criteria:

• Subjects with a history of organic diseases that could cause dyspepsia
• Subjects with hypersensitivity to investigational drugs and similar drugs
• Pregnant or breastfeeding women